ACAD
48.19
-0.62
-1.27%
AEMD
9.5
-0.49
-4.90%
APRI
1.38
-0.06
-4.17%
ARNA
4.06
+0.02
+0.50%
ATEC
1.36
0.00
0.00%
CNAT
4.49
-0.25
-5.27%
CRXM
0.3
0.00
0.00%
CYTX
0.427
-0.014
-3.0682%
DXCM
84.53
-0.12
-0.14%
GNMK
8.04
-0.46
-5.41%
HALO
23.03
-0.31
-1.33%
ILMN
216.7
-2.6
-1.19%
INNV
0.155
0.00
0.00%
INO
7.25
-0.04
-0.55%
ISCO
0.043
0.00
0.00%
ISIS
53.96
-0.97
-1.77%
LGND
108.74
+0.48
+0.44%
LPTN
0.264
-0.006
-2.1111%
MBVX
2.01
-0.15
-6.94%
MEIP
1.49
-0.07
-4.49%
MNOV
3.73
-0.02
-0.53%
MRTX
27.96
-0.65
-2.27%
MSTX
0.43
-0.017
-3.8014%
NBIX
48.99
-1.13
-2.25%
NUVA
55.19
+0.18
+0.33%
ONCS
5.98
-0.08
-1.32%
ONVO
3.35
-0.03
-0.89%
OREX
3.96
-0.04
-1.00%
OTIC
25.97
+0.2
+0.78%
QDEL
20.62
-0.09
-0.43%
RCPT
228.56
+0.7
+0.31%
RGLS
7.99
-0.21
-2.56%
RMD
55.4
-2.55
-4.40%
SCIE
0.018
0.00
0.00%
SPHS
0.844
-0.026
-2.944%
SRNE
21.17
+0.39
+1.88%
TROV
7.88
0.00
0.00%
VICL
0.628
-0.016
-2.484%
ZGNX
19.6
+0.29
+1.50%
ACAD
48.19
-0.62
-1.27%
AEMD
9.5
-0.49
-4.90%
APRI
1.38
-0.06
-4.17%
ARNA
4.06
+0.02
+0.50%
ATEC
1.36
0.00
0.00%
CNAT
4.49
-0.25
-5.27%
CRXM
0.3
0.00
0.00%
CYTX
0.427
-0.014
-3.0682%
DXCM
84.53
-0.12
-0.14%
GNMK
8.04
-0.46
-5.41%
HALO
23.03
-0.31
-1.33%
ILMN
216.7
-2.6
-1.19%
INNV
0.155
0.00
0.00%
INO
7.25
-0.04
-0.55%
ISCO
0.043
0.00
0.00%
ISIS
53.96
-0.97
-1.77%
LGND
108.74
+0.48
+0.44%
LPTN
0.264
-0.006
-2.1111%
MBVX
2.01
-0.15
-6.94%
MEIP
1.49
-0.07
-4.49%
MNOV
3.73
-0.02
-0.53%
MRTX
27.96
-0.65
-2.27%
MSTX
0.43
-0.017
-3.8014%
NBIX
48.99
-1.13
-2.25%
NUVA
55.19
+0.18
+0.33%
ONCS
5.98
-0.08
-1.32%
ONVO
3.35
-0.03
-0.89%
OREX
3.96
-0.04
-1.00%
OTIC
25.97
+0.2
+0.78%
QDEL
20.62
-0.09
-0.43%
RCPT
228.56
+0.7
+0.31%
RGLS
7.99
-0.21
-2.56%
RMD
55.4
-2.55
-4.40%
SCIE
0.018
0.00
0.00%
SPHS
0.844
-0.026
-2.944%
SRNE
21.17
+0.39
+1.88%
TROV
7.88
0.00
0.00%
VICL
0.628
-0.016
-2.484%
ZGNX
19.6
+0.29
+1.50%
Home » Hugo Villar, Ph.D., MBA-Bio

Hugo Villar, Ph.D., MBA-Bio

Hugo O. Villar Ph.D., MBA is director for Science and Technology programs at UC San Diego Extension. He is also President of Altoris, Inc. a San Diego based specializing in information management for the biotech and pharmaceutical industries and providing consulting on discovery technologies. He was Vice President for Chemoproteomics at Triad Therapeutics and Vice President of Discovery Technologies at Telik, Inc. His work resulted in over 80 publications and 18 patents on the development of technologies for drug discovery. He has a Ph.D. in Chemistry and an MBA with a concentration in Pharmaceuticals and Helathcare.